| Perpetual Limited (PPT) ORDINARY FULLY PAID |
Financials |
$2,221 |
Appendix 4E
|
28 Aug 2025 9:04AM |
$22.140 |
$19.200 |
fallen by
13.28%
|
|
PPT - Price-sensitive ASX Announcement
Full Release
Key Points
- Announcement of FY25 financial results on 28 August 2025.
- Revenue from ordinary activities reached AUD 1,379.1 million, a 2% increase.
- Net profit after tax attributable to equity holders dropped by 88% to AUD 58.2 million.
- Underlying net profit after tax excluding significant items was AUD 204.1 million, a 1% decrease.
- Structured investments revenue totaled AUD 11.4 million.
- Total dividend declared was 115 cents per share, with a final dividend of 54 cents per share.
- Final dividend payment scheduled for 3 October 2025.
- Dividend Reinvestment Plan (DRP) will not include a discount.
- Net tangible assets per security declined to AUD 2.12 from AUD 2.60.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Betmakers Technology Group Ltd (BET) ORDINARY FULLY PAID |
Consumer Discretionary |
$246 |
FY25 Results
|
28 Aug 2025 9:04AM |
$0.150 |
$0.220 |
risen by
46.67%
|
|
BET - Price-sensitive ASX Announcement
Full Release
Key Points
- FY25 marked a major transformation year for Betmakers.
- Achieved full-year positive Adjusted EBITDA of $4.6 million.
- Revenue increased by 5.6% to $85.1 million.
- Gross margin improved to 64%, with significant margin expansion in 2H FY25.
- Acquisition of Las Vegas Dissemination Company to expand US market footprint.
- Apollo platform rollout and GTX digital tote development improved efficiency.
- Focus on global growth and market penetration in FY26.
- Strengthened partner network and enhanced technology offerings.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lifestyle Communities Limited (LIC) ORDINARY FULLY PAID |
Real Estate |
$646 |
Full Year Results Release
|
28 Aug 2025 9:04AM |
$5.160 |
$5.310 |
risen by
2.91%
|
|
LIC - Price-sensitive ASX Announcement
Full Release
Key Points
- Statutory loss of $195.3 million due to VCAT decision impacts.
- Operating profit of $45.2 million in FY25.
- Improved sales momentum in the second half of FY25.
- 40% reduction in inventory levels.
- Initiated de-leveraging and capital recovery strategies.
- Refreshed strategy focusing on Australian downsizers.
- Appeal of VCAT decision planned to potentially reverse adjustments.
- Focus on further de-leveraging and cash flow improvement in FY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lifestyle Communities Limited (LIC) ORDINARY FULLY PAID |
Real Estate |
$646 |
Full Year Results Release
|
28 Aug 2025 9:04AM |
$5.160 |
$5.310 |
risen by
2.91%
|
|
LIC - Price-sensitive ASX Announcement
Full Release
Key Points
- Statutory profit after tax declined from $50 million in FY24 to a loss of $195.3 million in FY25.
- Provision for repayment of DMF and investment property write-downs following VCAT decision.
- Operating profit after tax was $45.2 million in FY25.
- Positive operating cash flow of $4.6 million in FY25.
- Reduction in inventory levels by 25% over six months.
- Refreshed strategy focused on Australian downsizers.
- Expecting new development cycle in late FY26.
- Priorities include further de-leveraging and inventory reduction.
- Lifestyle Communities CEO emphasized strategic focus on homeowner choice and certainty.
- Macro trends support business positioning with an increase in population over 55 in Victoria.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Betmakers Technology Group Ltd (BET) ORDINARY FULLY PAID |
Consumer Discretionary |
$246 |
FY25 Results Presentation
|
28 Aug 2025 9:03AM |
$0.150 |
$0.220 |
risen by
46.67%
|
|
BET - Price-sensitive ASX Announcement
Full Release
Key Points
- 5.6% growth in 2H FY25
- Record $5.9 million adjusted EBITDA in 2H FY25
- $6.4 million operating cash flow
- Technology-led transformation
- $18.8 million in cash, no debt
- Diversified and recurring international revenue
- Improved gross margins
- Focus on digital platform and data/API services
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Betmakers Technology Group Ltd (BET) ORDINARY FULLY PAID |
Consumer Discretionary |
$246 |
FY25 Results Presentation
|
28 Aug 2025 9:03AM |
$0.150 |
$0.220 |
risen by
46.67%
|
|
BET - Price-sensitive ASX Announcement
Full Release
Key Points
- 5.6% revenue growth in 2H FY25
- Record half-year performance with $5.9m Adjusted EBITDA
- 20% reduction in operating costs from FY24 to FY25
- Strong balance sheet with no debt
- Technology-led transformation completed
- FY25 revenue was $85.1 million with 74% from international markets
- Acquisition of LVDC to expand in Nevada gaming market
- Integration of AI and machine learning for operational optimization
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lifestyle Communities Limited (LIC) ORDINARY FULLY PAID |
Real Estate |
$646 |
Appendix 4G and Corporate Governance Statement
|
28 Aug 2025 9:03AM |
$5.160 |
$5.310 |
risen by
2.91%
|
|
| Telix Pharmaceuticals Limited (TLX) ORDINARY FULLY PAID |
Health Care |
$5,759 |
Telix Provides Regulatory Update on TLX250-CDx
|
28 Aug 2025 9:03AM |
$18.400 |
$16.950 |
fallen by
7.88%
|
|
TLX - Price-sensitive ASX Announcement
Full Release
Key Points
- Telix received a Complete Response Letter from the FDA for TLX250-CDx.
- The FDA pointed out deficiencies in the Chemistry, Manufacturing, and Controls package.
- Additional data is required to establish comparability between trial and commercial manufacturing processes.
- Notices of deficiency were issued to two third-party manufacturing partners.
- Telix will address these concerns promptly and has requested a Type A meeting with the FDA.
- The company's revenue guidance for 2025 remains unaffected.
- Patient access to TLX250-CDx will continue through the FDA-approved expanded access program.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Emyria Limited (EMD) ORDINARY FULLY PAID |
Health Care |
$38 |
Appendix 4E & Annual Report for the Year Ended 30 June 2025
|
28 Aug 2025 9:03AM |
$0.050 |
$0.047 |
fallen by
6%
|
|
EMD - Price-sensitive ASX Announcement
Full Release
Key Points
- Loss after income tax for 2025 was $3,142,758.
- Revenue from patients declined to $1,309,227.
- Assets increased to $6,618,498.
- Net equity stood at $5,305,472.
- Cash flows from financing activities resulted in a net increase of $4,627,445.
- Emyria's issued capital and performance rights were significant contributors to equity.
- Key management personnel saw changes in executive roles.
- The company received high support for its remuneration report at the 2024 AGM.
- The directors' report detailed remuneration and policy adherence.
- Commitment to capital management and shareholder returns was emphasized.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| DroneShield Limited (DRO) ORDINARY FULLY PAID |
Industrials |
$1,959 |
Project LAND 156 Update
|
28 Aug 2025 9:03AM |
$3.200 |
$2.120 |
fallen by
33.75%
|
|
DRO - Price-sensitive ASX Announcement
Full Release
Key Points
- DroneShield Limited was not selected as the Systems Integration Partner for Project LAND 156.
- The SIP contract for LAND 156 was awarded to Leidos Australia.
- DroneShield previously won two contracts under the initial phase of LAND 156, including a $5 million contract.
- The total value of the LAND 156 program is $1.3 billion over the next 10 years.
- DroneShield reported an all-time record revenue of $72.3 million and a record profit before tax of $5.2 million for the half-year.
- DroneShield's technology is used globally, including in Ukraine and by over 30 militaries and law enforcement agencies.
- There is a surge in global demand for DroneShield's capabilities, highlighted by a $61.6 million sale to a European customer.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Betmakers Technology Group Ltd (BET) ORDINARY FULLY PAID |
Consumer Discretionary |
$246 |
Appendix 4E and Annual Report
|
28 Aug 2025 9:02AM |
$0.150 |
$0.220 |
risen by
46.67%
|
|
BET - Price-sensitive ASX Announcement
Full Release
Key Points
- BetMakers Technology Group Ltd reported a loss of $26,420,000 for the year ending 30 June 2025, with revenues down by 10.6% to $85,121,000.
- The company achieved both positive Adjusted EBITDA and operating cash flow for the first time, with Adjusted EBITDA reaching $4.6 million.
- The loss includes significant items such as deferred tax asset movement, share-based payments, and impairment of assets.
- No dividends were declared for the financial period.
- The company has no control gained or lost over entities, and no new foreign entity reports.
- Net tangible assets per ordinary security decreased from 5.46 cents in 2024 to 3.26 cents in 2025.
- The Global Betting Services and Global Tote divisions experienced revenue decreases, primarily due to the loss of a key customer and challenging market conditions.
- Strategic initiatives include scaling the Apollo platform, advancing the GTX platform, and acquiring the Las Vegas Dissemination Company.
- The company secured key partnerships and expanded internationally, including agreements with UK Tote Group and Hollywoodbets.
- BetMakers ended the financial year with $18.8 million in cash and zero debt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Comms Group Ltd (CCG) ORDINARY FULLY PAID |
Communication Services |
$46 |
Dividend/Distribution - CCG
|
28 Aug 2025 9:02AM |
$0.060 |
$0.083 |
risen by
38.33%
|
|
| Biome Australia Limited (BIO) ORDINARY FULLY PAID |
Consumer Staple |
$65 |
Biome Secures Distribution with Mecca and GoVita
|
28 Aug 2025 9:02AM |
$0.520 |
$0.285 |
fallen by
45.19%
|
|
BIO - Price-sensitive ASX Announcement
Full Release
Key Points
- Biome Australia's strategic distribution with Mecca and Go Vita.
- Launch of Activated Probiotics® in Mecca's Melbourne flagship store.
- Expansion into premium beauty retail and health food sectors.
- Access to over 500 independent health food retailers through Go Vita.
- Focus on practitioner-recommended, evidence-based health solutions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Biome Australia Limited (BIO) ORDINARY FULLY PAID |
Consumer Staple |
$65 |
Biome Secures Distribution with Mecca and GoVita
|
28 Aug 2025 9:02AM |
$0.520 |
$0.285 |
fallen by
45.19%
|
|
BIO - Price-sensitive ASX Announcement
Full Release
Key Points
- Biome Australia secures distribution with Mecca and Go Vita.
- Launching Activated Probiotics at Mecca's flagship store in Melbourne.
- Go Vita partnership expands access to over 500 independent health food retailers.
- Mecca's wellness hub to feature Activated Probiotics alongside other wellness brands.
- Biome's entry into premium beauty retail with Mecca.
- Go Vita's practitioner-focused approach aligns with Biome's strategy.
- Biome aims to diversify distribution while maintaining practitioner-recommended model.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| FleetPartners Group Limited (FPR) ORDINARY FULLY PAID |
Financials |
$827 |
Update - Notification of buy-back - FPR
|
28 Aug 2025 9:02AM |
$2.820 |
$3.870 |
risen by
37.23%
|
|
| Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$109 |
FY25 Annual Report
|
28 Aug 2025 9:01AM |
$0.130 |
$0.115 |
fallen by
11.54%
|
|
| Comms Group Ltd (CCG) ORDINARY FULLY PAID |
Communication Services |
$46 |
FY25 Appendix 4E and Full Year Statutory Accounts
|
28 Aug 2025 9:01AM |
$0.060 |
$0.083 |
risen by
38.33%
|
|
CCG - Price-sensitive ASX Announcement
Full Release
Key Points
- Comms Group Ltd reported a revenue increase of 2.1% to $56.6 million.
- Net loss after tax for the year was $0.7 million due to acquisition and restructuring costs.
- The acquisition of TasmaNet was completed in June 2025, expected to enhance capabilities.
- Operating segments include Global, SME, ICT, and TasmaNet.
- Final dividend declared was 0.125 cents per share.
- The report outlines management of a term loan and financial strategies.
- The company expects to continue operations on a going concern basis.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Comms Group Ltd (CCG) ORDINARY FULLY PAID |
Communication Services |
$46 |
FY25 Appendix 4E and Full Year Statutory Accounts
|
28 Aug 2025 9:01AM |
$0.060 |
$0.083 |
risen by
38.33%
|
|
CCG - Price-sensitive ASX Announcement
Full Release
Key Points
- Comms Group Limited reported a loss for FY25 amounting to $648,150.
- The company's total revenue for FY25 was $56.6 million.
- Total equity at the end of FY25 was $36,734,186, up from $31,774,374 at the end of FY24.
- The net cash inflow from operating activities was $3,647,235 for FY25.
- The company declared a dividend of 0.25 cents per share during FY25.
- The share price at the end of FY25 was 5.4 cents per share.
- Performance rights and options were significant components of employee compensation.
- The financial statements are prepared in accordance with Australian accounting standards.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Micro-X Limited (MX1) ORDINARY FULLY PAID |
Health Care |
$20 |
MX1 - 2025 Full Year Results Presentation
|
28 Aug 2025 9:01AM |
$0.079 |
$0.027 |
fallen by
65.82%
|
|
MX1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Secured $36.6M funding for product development.
- $25M ARPA-H program for Full Body CT.
- $5.6M partnership with Billion Prima.
- FY25 revenue totaled $13.1M.
- Focus on minimizing unfunded costs.
- Project revenue growth offsetting product sales decline.
- Advancements in 3D CT imaging technology.
- Major US supply agreement for Rover Plus.
- Clinical trials for head CT imaging to start in 2025.
- Head CT imaging system launch planned for 2027.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Micro-X Limited (MX1) ORDINARY FULLY PAID |
Health Care |
$20 |
MX1 - 2025 Full Year Results Presentation
|
28 Aug 2025 9:01AM |
$0.079 |
$0.027 |
fallen by
65.82%
|
|
MX1 - Price-sensitive ASX Announcement
Full Release
Key Points
- FY25 total revenue: $13.1 million.
- Partnership funding secured: $36.6 million.
- Strategic partnership with Billion Prima for baggage scanner.
- ARPA-H funding for Full Body CT program.
- Head CT technology advancing to clinical trials.
- Rover Plus sales strategized for major healthcare groups.
- Reduction in unfunded development costs by 46%.
- Focus on monetizing security technology through partnerships.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tetratherix Limited (TTX) ORDINARY FULLY PAID |
Health Care |
$216 |
Appendix 4E and 2025 Annual Report
|
28 Aug 2025 9:01AM |
$4.100 |
$7.320 |
risen by
78.54%
|
|
TTX - Price-sensitive ASX Announcement
Full Release
Key Points
- Tetratherix Limited reported a loss after income tax of $9.43 million for the year ended June 30, 2025.
- The company successfully listed on the ASX during the financial year 2025.
- Significant milestones include the development of a new polymer technology.
- The group holds a 50% share in a joint venture, Tutelix Pty Ltd, focusing on bio stealth hydrogel for oncology.
- Net cash used in operating activities was $2.67 million for the year.
- Net cash from financing activities amounted to $32.47 million.
- The company did not declare or recommend any dividends for the financial year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Centuria Industrial REIT (CIP) ORDINARY UNITS FULLY PAID |
Real Estate |
$1,954 |
Update - Notification of buy-back - CIP
|
28 Aug 2025 9:01AM |
$3.410 |
$3.130 |
fallen by
8.21%
|
|
| Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$109 |
FY25 Appendix 4E
|
28 Aug 2025 9:00AM |
$0.130 |
$0.115 |
fallen by
11.54%
|
|
LDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 11.4% to US$12,400,000.
- Loss after tax reduced by 16.4% to US$7,183,000.
- Net tangible assets per share improved from (0.37) to (0.14) US cents.
- No dividends were declared during the fiscal year.
- Financial statements audited with an unmodified opinion.
- Material uncertainty over the ability to continue as a going concern.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$109 |
FY25 Appendix 4E
|
28 Aug 2025 9:00AM |
$0.130 |
$0.115 |
fallen by
11.54%
|
|
LDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 11.4% to US$12,400,000.
- Loss from ordinary activities after tax decreased to US$7,183,000.
- Net tangible assets per ordinary security improved to US$0.14.
- No control was gained or lost over entities.
- No dividends were declared or paid.
- Audit opinion unmodified but notes a material uncertainty over going concern.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Light & Wonder Inc. (LNW) CHESS DEPOSITARY INTERESTS 1:1 |
Consumer Discretionary |
$10,009 |
Statement of Changes in Beneficial Ownership - O. Chow
|
28 Aug 2025 9:00AM |
$145.090 |
$129.900 |
fallen by
10.47%
|
|
Call 1300 880 160
Start a chat
Schedule a call
